Dr.pharmacist
ZITUVIMET

ZITUVIMET

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

OTC DrugZITUVIMET
Reviewed by Younghun Cho

Pharmacist's Verdict

This is a highly effective prescription-only medication for Type 2 diabetes, combining two proven drugs to lower blood sugar more effectively than either one alone.

Ingredient Analysis

Metformin Hydrochloride

Sitagliptin

Pros & Cons

Pros

  • Combines two different medications into a single pill, making it easier to take.
  • Targets blood sugar control through two separate mechanisms for better results.
  • Low risk of causing dangerously low blood sugar (hypoglycemia) when used on its own.
  • Metformin, one of the ingredients, is a trusted, first-choice drug for diabetes management.

Cons

  • This is a prescription drug and is NOT available over-the-counter; it requires a doctor's diagnosis and supervision.
  • Common side effects, especially when starting, include diarrhea, nausea, and stomach upset.
  • Carries a risk for rare but serious side effects, including lactic acidosis (a buildup of acid in the blood) and pancreatitis (inflammation of the pancreas).
  • Requires regular blood tests to monitor kidney function.
  • Not suitable for patients with severe kidney disease.

Safety Information

Potential Side Effects

6 ADVERSE REACTIONS The following adverse reactions are also discussed elsewhere in the prescribing information: Lactic Acidosis [see Warnings and Precautions ( 5.1 )] Pancreatitis [see Warnings and Precautions ( 5.2 )] Heart Failure [see Warnings and Precautions ( 5.3 )] Acute Renal Failure [see Warnings and Precautions ( 5.4 )] Vitamin B12 Deficiency [see Warnings and Precautions ( 5.5 )] Hypoglycemia with Concomitant Use with Insulin or Insulin Secretagogues [see Warnings and Precautions ( 5.6 )] Hypersensitivity Reactions [see Warnings and Precautions ( 5.7 )] Severe and Disabling Arthralgia [see Warnings and Precautions ( 5.8 )] Bullous Pemphigoid [see Warnings and Precautions ( 5.9 )] Most common adverse reactions (incidence ≥5% of patients simultaneously started on sitagliptin and m…

Is ZITUVIMET safe for you?

See pregnancy, interactions, and common concerns answered in our pharmacist safety FAQ.

Read safety review →

References

  1. 1.
    FDA Drug Label — ZITUVIMET

    FDA DailyMed: ZITUVIMET · FDA

  2. 2.
    Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis.

    Zhang YS, Zheng YD, Yuan Y, et al., Frontiers in endocrinology, 2021 · PubMed

  3. 3.
    Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis.

    Domecq JP, Prutsky G, Leppin A, et al., The Journal of clinical endocrinology and metabolism, 2015 · PubMed

  4. 4.
    Drug-Induced Acute Pancreatitis: A Real-World Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database.

    Li D, Wang H, Qin C, et al., Clinical pharmacology and therapeutics, 2024 · PubMed

  5. 5.
    Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation.

    Johnston R, Uthman O, Cummins E, et al., Health technology assessment (Winchester, England), 2017 · PubMed

  6. 6.
    Sitagliptin.

    Lyseng-Williamson KA, Drugs, 2007 · PubMed